Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancer
Abstract Background The MALAT1 lncRNA acts as an oncogene in Prostate cancer (PC); thus, it can be severe as a cancer biomarker. Methods Using bioinformatics datasets including (HTSeq-Counts, GDC, and TCGA) 5501 gene expression profiling specimens were gathered. Then, expression profiles and sample...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Genes and Environment |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41021-022-00252-3 |